approval
saveLINZESS (LINACLOTIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLINZESS (LINACLOTIDE) — FDA approvalNov 4, 2025 · 335d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJun 12, 2023 · 1211d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalAug 24, 2021 · 1868d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalApr 12, 2021 · 2002d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalSep 22, 2020 · 2204d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalMar 8, 2017 · 3498d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 25, 2017 · 3540d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 6, 2017 · 3559d ago
same company · ±60 days · 6
- approvalESCITALOPRAM OXALATE — FDA approvalDec 13, 2014
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalDec 24, 2014
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalNov 20, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalNov 20, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalNov 20, 2014
- approvallinaclotide: LINZESS (LINACLOTIDE) — FDA approvalJan 5, 2015
comments(0)
5-min edit window · permanent after that